Compare United States Natural Gas Fund (UNG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United States Natural Gas Fund vs State Street SPDR S&P Biotech ETF — how do they compare? United States Natural Gas Fund trades at $10.4, while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| UNG | XBI | |
|---|---|---|
Sector | Commodities - Energy | Broad Market / Factor |
52-Week High | $16.90 | $164.28 |
52-Week Low | $10.15 | $85.16 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
